Results 11 to 20 of about 1,472,414 (411)
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
This review provides an update on the current clinical, epidemiological and pathophysiological evidence alongside the diagnostic, prevention and treatment approach to chemotherapy-induced peripheral neuropathy (CIPN).
J. Burgess+10 more
semanticscholar +1 more source
Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
Peripheral neuropathy is one of the most common side effects of chemotherapy, affecting up to 60% of all cancer patients receiving chemotherapy. Moreover, paclitaxel induces neuropathy in up to 97% of all gynecological and urological cancer patients.
Ines Klein, H. Lehmann
semanticscholar +1 more source
PURPOSE To update the ASCO guideline on the recommended prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer survivors.
C. Loprinzi+15 more
semanticscholar +1 more source
Painful diabetic peripheral neuropathy can be intractable with a major impact, yet the underlying pain mechanisms remain uncertain. A range of neuronal and vascular biomarkers was investigated in painful diabetic peripheral neuropathy (painful-DPN) and ...
Pallai Shillo+7 more
doaj +1 more source
The integrated stress response contributes to tRNA synthetase–associated peripheral neuropathy
Description Defeating peripheral neuropathy The mechanisms underlying peripheral neuropathies are not well understood. Spaulding et al. studied mouse models of the inherited Charcot-Marie-Tooth (CMT) disease, which is caused by mutations in transfer RNA (
E. Spaulding+22 more
semanticscholar +1 more source
tRNA overexpression rescues peripheral neuropathy caused by mutations in tRNA synthetase
Description Defeating peripheral neuropathy The mechanisms underlying peripheral neuropathies are not well understood. Spaulding et al. studied mouse models of the inherited Charcot-Marie-Tooth (CMT) disease, which is caused by mutations in transfer RNA (
A. Zuko+16 more
semanticscholar +1 more source
Dabrafenib Promotes Schwann Cell Differentiation by Inhibition of the MEK-ERK Pathway
Schwann cell differentiation involves a dynamic interaction of signaling cascades. However, much remains to be elucidated regarding the function of signaling molecules that differ depending on the context in which the molecules are engaged.
Kyuhee Park+4 more
doaj +1 more source
Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy
Bortezomib, a first-generation proteasome inhibitor widely used in chemotherapy for hematologic malignancy, has effective anti-cancer activity but often causes severe peripheral neuropathy.
Shota Yamamoto, N. Egashira
semanticscholar +1 more source
Inflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)—New Aspects
The pathogenesis of diabetic neuropathy is complex, and various pathogenic pathways have been proposed. A better understanding of the pathophysiology is warranted for developing novel therapeutic strategies.
P. Baum+4 more
semanticscholar +1 more source
BackgroundTrench foot, or non-freezing cold injury (NFCI), results from cold exposure of sufficient severity and duration above freezing point, with consequent sensory and vascular abnormalities which may persist for years.
Praveen Anand+5 more
doaj +1 more source